• Aucun résultat trouvé

SERBIA BURDEN OF CANCER

N/A
N/A
Protected

Academic year: 2022

Partager "SERBIA BURDEN OF CANCER"

Copied!
2
0
0

Texte intégral

(1)

Total # cancer cases (2018)

Total # cancer deaths (2018)

47,960 26,919

33.4%

aPAF, cancer deaths bPAF, cancer cases cPAF, melanoma cases

TRENDS

Estimated past and future trends in total cases per year (breast and lung) Probability of premature death from cancer per year

INVESTMENT CASE (2019)

*Upper middle income

At this income level, investing in a package of essential services and scaling-up coverage will:

Costs per year Projected lives saved per year

Cancer Country Profile 2020

UV (2012)c Occupational risk (2017)a

78.3% 2.4%

8,772,228

Premature deaths from NCDs (2016)

Cancer as % of NCD premature deaths (2016)

8.5%

PAFs

(population attributable fractions)

28,147

Alcohol (2016)a Infections (2012)b Obesity (2012)b

8.9% 5.7%

SERBIA

BURDEN OF CANCER

42.4%

Total population (2019)

Tobacco (2017)a

12.1%

5.4%

2.8%

12.8%

3.3%

16.5%

2.6%

3.1%

6.6%

2.5%

8.0%

3.4%

2.0%

12.0%

1.4%

25.3%

1.5%

5.5%

4.7%

3.7%

Breast Bladder Cervix uteri Colorectum Corpus uteri Lung Melanoma of skin Pancreas Prostate Stomach

Most common cancer cases (2018)

Incidence Mortality

0 1,000 2,000 3,000 4,000 5,000 6,000

2020 2022 2024 2026 2028 2030

10.96%

10.93%11.27%11.35%11.40%10.96%10.92%10.85%10.90%10.87%10.82%10.43%10.25%10.02%

10.06%

9.48%9.39%9.30%9.20%9.11%9.02%8.93%8.84%8.74%8.65%8.56%8.47%

8.38%

9.33%9.09%8.85%8.61%8.37%8.13%7.89%7.65%7.41%7.16%6.92%6.68%

6.44%

2.00%

7.00%

12.00%

17.00%

2000 2005 2010 2015 2020 2025 2030

Past trends Projected linear trend SDG target 5,422

7,263 5,809

7,912

5,741

7,965

- 1,000 2,000 3,000 4,000 5,000 6,000 7,000 8,000 9,000

Breast cancer Lung cancer

2012 2018 2040

- 1.00 2.00 3.00 4.00 5.00 6.00 7.00 8.00 9.00

2020 2022 2024 2026 2028 2030

US$ (per capita)

(2)

HEALTH SYSTEM CAPACITY

aper 10,000 cancer patients

WORKFORCE

aper 10,000 cancer patients

Quality of mortality registration*** 2007-2016 Medium 2019 don't know

# of radiation oncologista 2019 n/a

2019 10.0

# of mammographsa 2020 26.1 # of surgeonsa n/a n/a

# of CT scannersa 2020 27.1 # of radiologista 2019 n/a

# of MRI scannersa 2020 12.3 # of nuclear medicine physiciana 2019 13.3

# of PET or PET/CT scannersa 2020 0.4 # of medical & pathology lab scientistsa 2016 n/a

Integrated NCD plan 2019 operational 2019 0.8

NCCP (including cancer types) 2019 operational 2019 3 cancer(s)

MPOWER measures fully implemented and

achieved 2018

1

Pathology services 2019 generally available

Cancer management guidelines 2019 yes 2019 don't know

Palliative care included in their operational,

integrated NCD plan 2019 yes

2015-2017 1490

Breast cancer screening program 2019 yes *Defined daily doses for statistical purposes (S-DDD) per miliion inhabitants per day Breast cancer screening program: Starting

age, target population 2019

50

GLOBAL INITIATIVES

Elimination of Cervical Cancer Global Initiative for Childhood Cancer

HPV vaccination programme coverage 2018 n/a 2020 222

Cervical cancer screening 2019 yes Early detection programme/guidelines 2019 no

Screening programme type 2019 organised Defined referral system 2019 yes

Screening programme method 2019 PAP smear

Screening participation rates 2019

Early detection programme/guidelines 2019 yes

Defined referral system 2019 yes

Annual cancer cases (0-14 years old) Palliative care availability:

community/home-based care 2019 generally available Available staff in Ministry of Health who

dedicates significant proportion of their time to cancer

# of medical physicista

Early detection programme/ guidelines for 4 cancers (breast, cervix, colon, childhood)

Cancer Country Profile 2020

PBCR

2019 6.5

FORMULATING RESPONSE

# of external beam radiotherapy (photon,electron)a

SERBIA

10%-50%

Annual cancer cases (0-14 years old) Bone marrow transplantation capacity

# Public cancer centres per 10,000 cancer patients

# of treatment services (surgery,

radiotherapy, chemotherapy) 2019 3 Availability of opioids* for pain

management Availability of population-based cancer

registry (PBCR)** 2019

49

11 6 21 9 5 121

Acute lymphoid leukaemia Hodgkin lymphoma Burkitt lymphoma CNS, low grade tumours Retinoblastoma Wilms tumour Other childhood cancer

Références

Documents relatifs

Cervical cancer screening 2019 yes Early detection programme/guidelines 2019 no. Screening programme type 2019 organised Defined referral system

Cervical cancer screening 2019 yes Early detection programme/guidelines 2019 no. Screening programme type 2019 organised Defined referral system

Cervical cancer screening 2019 yes Early detection programme/guidelines 2019 no. Screening programme type 2019 organised Defined referral system

Cervical cancer screening 2019 yes Early detection programme/guidelines 2019 no. Screening programme type 2019 organised Defined referral

Cervical cancer screening 2019 yes Early detection programme/guidelines 2019 no. Screening programme type 2019 organised Defined referral system

Cervical cancer screening 2019 yes Early detection programme/guidelines 2019 no. Screening programme type 2019 organised Defined referral system

Cervical cancer screening 2019 yes Early detection programme/guidelines 2019 yes. Screening programme type 2019 organised Defined referral system

Cervical cancer screening 2019 yes Early detection programme/guidelines 2019 yes. Screening programme type 2019 organised Defined referral system